Large Language Models May Be Useful Adjuncts to Human Expert Consensus Panels

AI collage artistic photo

The Delphi method is commonly used for developing consensus documents such as clinical guidelines, diagnostic criteria, and healthcare policies when empirical evidence alone is insufficient. Delphi studies facilitate structured communication among experts through iterative rounds of anonymous feedback, minimizing the interpersonal influences that might bias individual judgment in face-to-face meetings. 

The conventional Delphi method requires extensive administrative coordination, substantial time commitment from busy specialists, and participation of a Delphi expert to create the statements to be evaluated. 

Abdelrahman Nimeri, MD, FACS, director of bariatric surgery in the Center for Weight Management and Wellness at Brigham and Women’s Hospital, Ahram Han, MD, of Seoul National University Hospital in Korea, and Young Suk Park, MD, PhD, and colleagues found in an exploratory study that a Delphi process involving large language models (LLMs) achieved high levels of consensus on medical statements, with substantial concordance to human expert decisions.  Read More

Augmented Reality for Advanced Neuronavigation for Arterial Control in Brain AVM Surgery

radiology image of AVM blood vessels in the brain

Arteriovenous malformations (AVMs) are rare and among the most complex cerebrovascular conditions treated in neurosurgery. Although surgical resection can be curative, it carries substantial risk, including hemorrhage and injury to surrounding brain tissue that may result in paralysis, visual loss, or other neurological deficits.

Nirav Patel, MD, a neurosurgeon at the Mass General Brigham Neuroscience Institute and director of Mass General Brigham’s Brain AVM Program, has led the development and refinement of innovative surgical strategies that leverage augmented reality, advanced neuronavigation, and multimodal neuromonitoring to improve the safety and precision of AVM microsurgery. These techniques focus on identifying and controlling arterial feeders before nidus dissection—a paradigm shift in AVM surgery. Read More

Composite Ultrasonic Findings Show Promise for Diagnosis of Adenomyosis

doctor working on an ultrasound machine

The gold standard for the diagnosis of adenomyosis is histopathology, which typically requires hysterectomy. Ultrasound has been proposed as a much less invasive, fertility-sparing alternative. In 2022, a consensus statement published in Ultrasound in Obstetrics & Gynecology listed direct and indirect sonographic findings suggestive of adenomyosis.

Researchers in the Department of Obstetrics and Gynecology at Brigham and Women’s Hospital, including Parmida Maghsoudlou, BA, and Yvette S. Groszmann, MD, MPH, aimed to validate the markers by evaluating them in patients with and without histopathologically confirmed adenomyosis. In The Journal of Minimally Invasive Gynecology, they say the composite of direct findings was 100% sensitive for adenomyosis. Read More

The First Large Cohort Analysis to Frame Spinal Cord Injury as a Chronic Disease

glowing-spinal-cord-inside-body

Traumatic spinal cord injury isn’t just a one-time event but also a chronic condition. Furthermore, people with a history of spinal cord injury are more likely to develop cardiovascular, neurological, psychiatric, and endocrine diseases—regardless of age, location of injury, or prior health status.

These are two key takeaways from research led by Mass General Brigham investigators published in JAMA Network Open.

“We have shown not only that these multisystem comorbidities are happening after spinal cord injury but also that they are associated with increased mortality risk,” says the corresponding author, neurologist Saef Izzy, MD, MBChB, FNCS, FAAN. “It’s time for action. We urgently need more programs that focus on screening and prevention in these patients.”

Building on Previous Research on Traumatic Brain Injury

Dr. Izzy, principal investigator of the Izzy Lab at Brigham and Women’s Hospital and head of the Brigham’s Immunology of CNS Injury Program, has led several studies analyzing the downstream effects of traumatic brain injury.

Another 2025 paper published in JAMA Network Open suggested that traumatic brain injury is a chronic condition that raises the risk of developing a malignant brain tumor. Earlier papers documented other long-term clinical consequences of brain injury, including heightened risks of cardiovascular, psychiatric, and other diseases.

Given the results of these and other studies, the researchers note in the new paper, “It is…possible that (traumatic spinal cord injury) can similarly increase the risk of systemic diseases.” The study is the first large cohort analysis to frame spinal cord injury as a chronic disease.

Dr. Izzy and his colleagues tracked the health of 1,038 patients with traumatic spinal cord injury treated at Mass General Brigham and 1,711 patients with spinal cord injury treated at the University of California Health System between January 1996 and January 2024. Over a follow-up period of up to 20 years, the researchers documented the incidence of chronic conditions and death in the patient group. These data were used to compare outcomes with matched control subjects without spinal cord injury.

Compared to the healthy control group, patients with a history of traumatic spinal cord injury had a significantly higher long-term risk of:

  • Cardiovascular conditions such as hypertension, hyperlipidemia, ischemic stroke, coronary artery disease, and diabetes
  • Neurological conditions such as dementia and seizures
  • Psychiatric conditions such as depression
  • Endocrine conditions such as erectile dysfunction and adrenal insufficiency

“Interestingly, the risk of these comorbidities was independent of prior brain injury,” Dr. Izzy says.

The researchers also found that traumatic spinal cord injury was associated with an increased risk of death, even in previously healthy patients.

A Call for Long-term, Multidisciplinary Care Strategies

Dr. Izzy says the study findings point to the need for long-term, multidisciplinary care strategies for managing individuals with spinal cord injury, including:

  • Implementing routine screening to identify patients at higher risk for an array of comorbidities
  • Educating primary care physicians on asking about spinal cord injury history when evaluating conditions like hypertension, as patients may have more extensive follow-up needs
  • Establishing a structured follow-up schedule for patients after discharge from the hospital, rehabilitation, or nursing home
  • Setting up EMR-based flags or care bundles to automatically identify patients with spinal cord injury history and prompt clinicians to schedule appropriate surveillance
  • Prioritizing early detection and timely intervention to optimize outcomes, including reducing mortality risk

The study authors acknowledge several limitations in the paper. Most prominently, the study relied on ICD codes that physicians entered to identify patient conditions. Although there is a strong correlation between codes and new diagnoses, patients with pre-existing conditions were excluded. Therefore, the results may be more applicable to individuals who were healthier at the beginning of the study period and may underestimate the incidence of chronic conditions among traumatic spinal cord injury patients.

“While this isn’t a prospective cohort yet, it provides an important foundation,” Dr. Izzy says. “Our goal is to build on these findings with a long-term prospective study following patients for 10 years or more. With support from research foundations and the National Institutes of Health, we can launch that next phase and generate even more definitive evidence.”

For now, Dr. Izzy and his colleagues at Mass General Brigham are focused on building collaborations with other institutions in the hopes of conducting more extensive studies of spinal cord injury patients at high risk of specific comorbidities.

“Expanding the number of patients will enable more refined endophenotyping of these cohorts,” Dr. Izzy says. “This will help us better understand how to monitor individuals over time and develop strategies to reduce long-term chronic disease burden.”

His recent work on traumatic spinal cord injury and traumatic brain injury is reshaping how clinicians—including Dr. Izzy himself—understand and approach these conditions.

“Ten years ago, we suspected these connections, but we didn’t yet have the data to prove them,” Dr. Izzy says. “Today, the evidence shows a strong epidemiologic link between brain and spinal trauma and a broad spectrum of chronic diseases. The next step is clear: earlier screening, smarter prevention, and better long-term care for patients.”

Improving Surgical Decision-making for Persons Living With Dementia

doctor sitting and talking with a patient

Limited longitudinal data on outcomes. An inability of the patient to fully participate in the discussion. Vague advance directives with multiple care partners (surrogates). These are among the many factors that complicate surgical decision-making with persons living with dementia (PLWD).

Complex challenges like these are exacerbated by the lack of evidence-based guidelines to inform clinicians who must recommend whether to proceed with surgery, a nonsurgical treatment, or no treatment at all. The goal of the Decisions Around Dementia and Surgery (DecADES) project is to fill this gap, thus improving surgical decision-making with PLWD as well as recovery when surgery is chosen. Read More

Addition of Neoadjuvant and Adjuvant Pembrolizumab Improves Event-free Survival in Locally Advanced HNSCC

Headshot of Dr. Uppaluri

In 2004, cisplatin was made part of standard care for resectable locally advanced head and neck squamous-cell carcinoma (HNSCC) with high risk features, but there’s been no major advance since then.

Ravindra Uppaluri, MD, PhD, surgeon scientist and physician lead at Brigham and Women’s Hospital, and colleagues recently demonstrated the efficacy and safety of adding neoadjuvant and adjuvant pembrolizumab to standard care in this setting. Their data from the first interim analysis of KEYNOTE-689 appears in The New England Journal of Medicine. Read More

Review: Chronic Cough and Pulmonary Manifestations of Reflux

headshot photo of Dr. Carroll

Gastroesophageal reflux disease (GERD) or laryngopharyngeal reflux disease (LPRD) can be the primary trigger for a cough, as refluxate can target the esophagus, hypopharynx, larynx, oropharynx, nasopharynx, trachea, distal airways, and perhaps even the nasal passages.

In Otolaryngology Clinics of North America, Thomas L. Carroll, MD, director of the Program for Voice, Swallowing and Upper Airway Health at Brigham and Women’s Hospital and medical director of the Otolaryngology Clinic, and a colleague review how to evaluate and manage reflux as a cause of chronic cough. Read More

Tirzepatide and Semaglutide More Cost-Effective Than Usual Weight Loss Interventions for Patients With Knee Osteoarthritis and Obesity

person holding knee in pain

Certain glucagon-like peptide-1 receptor agonists (GLP1RAs) have been shown to produce substantial weight loss and improve pain in people who have both knee osteoarthritis and obesity. Now, a computer simulation has shown that both tirzepatide and semaglutide would be widely considered cost-effective when compared directly with lifestyle interventions and bariatric surgery.

Elena Losina, PhD, director of the Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center at Brigham and Women’s Hospital and co-director of the Orthopaedic and Arthritis Center for Outcomes Research, Daniel J. Betensky, AB, and colleagues elaborate in Annals of Internal Medicine that tirzepatide would offer the most favorable return on investment when decision-makers set cost-effectiveness thresholds that exceed $57,400 per quality-adjusted life year (QALY). Read More

Systematic Review: The Role of Thermal Modalities in Injury Prevention

A person wearing a mask stands inside a cryotherapy chamber filled with mist, with part of a control panel visible to the side.

Delayed-onset muscle soreness (DOMS), a type of ultrastructural muscle injury, can result from strenuous activity. Athletes often use localized thermotherapy (e.g., heating pads and wraps), whole-body thermotherapy (e.g., hot-water immersion or sauna therapy), or cryotherapy (e.g., ice massage or cold-water immersion) to decrease or prevent DOMS and prevent future injury. 

Cold and heat play similar but unique roles in preventing DOMS and accelerating recovery from it, according to a systematic review by Elizabeth G. Matzkin, MD, surgical director of Women’s Musculoskeletal Health and chief of Women’s Sports Medicine in the Department of Orthopaedic Surgery at Brigham and Women’s Hospital. They describe their findings in Arthroscopy, Sports Medicine, and Rehabilitation.  Read More

Study Links History of Traumatic Brain Injury to Malignant Brain Tumors

Research led by Mass General Brigham investigators suggests traumatic brain injury (TBI) is a chronic condition that increases the risk of developing a malignant brain tumor. The paper was published in JAMA Network Open. Read More